GlassScriptPhysician profile
Helene P Henager
NPI 1386716504
$1,117.25
in general payments reported to CMS, 2019-2025
20 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $291 · 2022: $235 · 2023: $243 · 2024: $228 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $591.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $182.80 | 2021-2025 | Farxiga |
| Amgen INC. | $147.25 | 2022-2025 | Evenity, Prolia |
| Lilly USA, LLC | $127.51 | 2021-2024 | Mounjaro |
| Abbvie INC. | $103.97 | 2021-2024 | |
| Amarin Pharma, INC. | $83.15 | 2021-2022 | |
| Pfizer INC. | $62.31 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.29 | 2021 | |
| Paratek Pharmaceuticals, INC. | $55.16 | 2022-2023 | Nuzyra |
| Idorsia Pharmaceuticals US INC | $42.09 | 2023-2024 | Quviviq |
| Glaxosmithkline, LLC. | $36.01 | 2021-2023 | Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $31.34 | 2021 | |
| Harmony Biosciences LLC | $31.24 | 2023 | Wakix |
| Antares Pharma, INC. | $23.89 | 2024 | Xyosted |
| Novo Nordisk INC | $22.45 | 2021 | |
| Aimmune Therapeutics, INC. | $21.41 | 2025 | Zenpep |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $20.38 | 2025 | Ajovy |
| Phathom Pharmaceuticals, INC. | $18.99 | 2024 | Voquezna |
| Axsome Therapeutics, INC. | $18.20 | 2024 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $15.97 | 2022 | |
| Ibsa Pharma INC. | $11.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helene Henager listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.